Epidemiological surveillance of Creutzfeldt-Jakob in France;Le réseau de surveillance de la maladie de Creutzfeldt-Jakob

Revue Neurologique

Volumn 165, Issue 8-9, 2009, Pages 684-693

  Brandel, J P ^a,b   Salomon, D ^a   Capek, I ^c   Vaillant, V ^c   Alperovitch A ^a  

^a INSERM   (France)

^b PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^c InVS   (France)

Author keywords

Genetic Creutzfeldt Jakob disease; Iatrogenic Creutzfeldt Jakob disease; Sporadic Creutzfeldt Jakob disease; Transmissible spongiform encephalopathy; Variant Creutzfeldt Jakob disease

Indexed keywords

GROWTH HORMONE; METHIONINE; PROTEIN 14 3 3; VALINE;

BLOOD TRANSFUSION; BOVINE SPONGIFORM ENCEPHALOPATHY; CEREBROSPINAL FLUID ANALYSIS; CREUTZFELDT JAKOB DISEASE; DISEASE TRANSMISSION; EUROPE; FRANCE; GENE; GENOTYPE; HUMAN; IATROGENIC DISEASE; NEUROPATHOLOGY; PRION DISEASE; PRNP GENE; REVIEW;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; ANIMALS; CATTLE; CREUTZFELDT-JAKOB SYNDROME; FEMALE; FRANCE; GEOGRAPHY; HUMANS; IATROGENIC DISEASE; MALE; MIDDLE AGED; PRION DISEASES;

EID: 70049085864     PISSN: 00353787     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neurol.2009.04.006     Document Type: Review

References (36)

1. Alperovitch A., Zerr I., Pocchiari M., et al. Codon 129 prion protein genotype and sporadic Creutzfeldt-Jakob disease. Lancet 353 (1999) 1673-1674
2. Alperovitch A., and Huillard d'Aignaux J. Epidémie de nouveau variant de la maladie de Creutzfeldt-Jakob au Royaume-Uni : anatomie et physiologie des modèles prédictifs. Med Sci 18 (2002) 1081-1088
3. Bernoulli C., Siegfried J., Baumgartner G., et al. Danger of accidental person-to person transmission of Creutzfeldt-Jakob disease by surgery. Lancet 1 (1977) 478-479
4. Billette de Villemeur T.B., Beauvais P., Gourmelen M., and Richardet J.M. Creutzfeldt-Jakob disease in children treated with growth hormone. Lancet 337 (1991) 864-865
5. Brandel J.P., Preece M., Brown P., et al. Distribution of codon 129 genotype in human growth hormone-treated CJD patients in France and the UK. Lancet 362 (2003) 128-130
6. Brandel J.P., Health C.A., Head M.W., et al. variant CJD in France and the United-Kingdom: evidence for the same agent strain. Ann Neurol 65 (2009) 249-256
7. Brown P., Preece M., Brandel J.P., et al. Iatrogenic Creutzfeldt-Jakob disease at the millennium. Neurology 55 (2000) 1075-1081
8. Brown P., Brandel J.P., Preece M., and Sato T. Iatrogenic Creutzfeldt-Jakob disease: the waning of an era. Neurology 67 (2006) 389-393
9. Bruce M.E., Will R.G., Ironside J.W., et al. Transmissions to mice indicate that new variant CJD is caused by the BSE agent. Nature 389 (1997) 498-501
10. Chadeau-Hyam M., and Alpérovitch A. Risk of variant Creutzfeldt-Jakob disease in France. Int J Epidemiol 34 (2005) 46-52
11. Chazot G., Broussolle E., Lapras C., et al. New variant of Creutzfeldt-Jakob disease in a 26-year-old French man. Lancet 347 (1996) 1181
12. Collinge J., Sidle K.C.L., Meads J., et al. Molecular analysis of prion strain variation and the aetiology of "new variant" CJD. Nature 383 (1996) 685-690
13. Collins S., Law M.G., Fletcher A., et al. Surgical treatment and risk of sporadic Creutzfeldt-Jakob disease: a case-control study. Lancet 353 (1999) 693-697
14. Cooper J.D., and Bird S.M. Predicting incidence of variant Creutzfeldt-Jakob disease from UK dietary exposure to bovine spongiform encephalopathy for the 1940 to 1969 and post-1969 birth cohorts. Int J Epidemiol 32 (2003) 784-791
15. Deslys J.P., Jeagly A., Huillard d'Aignaux J., et al. Genotype at codon 129 and susceptibility to CJD. Lancet 343 (1998) 848-849
16. Duffy P., Wolf J., Collins G., De Voe A.G., Steeten B., Cowen D., et al. Possible person-to-person transmission of Creutzfeldt-Jakob disease. N Engl J Med 299 (1974) 692-693
17. EUROCJD Group. Genetic epidemiology of Creutzfeldt-Jakob disease in Europe. Rev Neurol (Paris) 157 (2001) 633-637
18. Foncin J., Gaches J., Cathala F., et al. Transmission iatrogène interhumaine possible de maladie de Creutzfeldt-Jakob avec atteinte des grains du cervelet. Rev Neurol 136 (1980) 280
19. Health Protection Agency. Fourth case of transfusion-associated variant-CJD. Health Protection Report 2007; 1.
20. Huillard d'Aignaux J., Cousens S.N., Delasnerie-Lauprêtre N., et al. Analysis of the geographical distribution of sporadic Creutzfeldt-Jakob disease in France between 1992 and 1998. Int J Epidemiol 31 (2002) 490-495
21. Huillard d'Aignaux J., Alpérovitch A., and Maccario J. A statistical model to identify the contaminated lots implicated in iatrogenic transmission of Creutzfeldt-Jakob disease among French human growth hormone recipients. Am J Epidemiol 147 (1998) 597-604
22. Ironside J.W., Bishop M.T., Connolly K., et al. Variant Creutzfedlt-Jakob disease: prion protein genotype analysis of positive appendix tissue samples from a retrospective prevalence study. Br Med J 332 (2006) 1186-1188
23. Laplanche J.L. Génétique moléculaire des formes familiales et sporadiques des maladies à prions humaines. Med Mal Infect 26 (1996) 254-270
24. Lasmézas C.I., Deslys J.P., Demalmay R., et al. BSE transmission to macaque. Nature 381 (1996) 743-744
25. Llewelyn C.A., Hewitt P.E., Knight R.S., et al. Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion. Lancet 363 (2004) 417-421
26. Mahillo-Fernandez I., de Pedro-Cuesta J., Bleda M.J., et al. Surgery and risk of sporadic Creutzfeldt-Jakob disease in Denmark and Sweden: registered-based case-control studies. Neuroepidemiology 31 (2008) 229-240
27. Palmer M.S., Dryden A.J., Hugues J.T., et al. Homozygous prion protein genotype predisposes to sporadic CJ disease. Nature 352 (1991) 340-342
28. Peden A.H., Head M.W., Ritchie D.L., et al. Preclinical vCJD after blood transfusion in a PRNP codon 129 heterozygous patient. Lancet 364 (2004) 527-529
29. Sanchez-Juan P., Cousens S.N., Will R.G., and van Duijn C.M. Source of variant Creutzfeldt-Jakob disease outside United Kingdom. Emerg Infect Dis 13 (2007) 1166-1169
30. Supervie V., and Costagliola D. The unrecognised French BSE epidemic. Vet Res 35 (2004) 349-362
31. Van Duijn C.M., Delasnerie-Lauprêtre N., Masullo C., et al. Case-control study of risk factors of Creutzfeldt-Jakob disease in Europe during 1993-1995. Lancet 351 (1998) 1081-1085
32. Ward H.J.T., Everington D., Croes E.A., et al. Sporadic Creutzfeldt-Jakob disease and surgery: a case-control study using community controls. Neurology 59 (2002) 543-548
33. Will R.G., and Matthews W.B. Evidence for case-to-case transmission of Creutzfeldt-Jakob disease. J Neurol Neurosurg Psychiatry 45 (1982) 235-238
34. Will R.G., Ironside J.W., Zeidler M., et al. A new variant of Creutzfeldt-Jakob disease in the UK. Lancet 347 (1996) 921-925
35. Wroe S.J., Pal S., Siddique D., et al. Clinical presentation and pre-mortem diagnosis of variant Creutzfeldt-Jakob disease associated with blood transfusion: a case report. Lancet 368 (2006) 2061-2067
36. Zeidler M, Gibbs CJ Jr, Meslin F. WHO Manual for strengthening diagnosis and surveillance of Creutzfeldt-Jakob Disease. Geneva, World Health Organization 1998, 1-75.